Publications by authors named "Maud Bagnoud"

Claim this Profile
P
Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis.
Maud Bagnoud, Jana Remlinger, Sandrine Joly, Marine Massy, Anke Salmen

CNS Neurosci Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations.
Jana Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy, Christopher Linington

Mult Scler Relat Disord· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations.
Jana Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy, Robert Hoepner

Neurol Neuroimmunol Neuroinflamm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling.
Maud Bagnoud, Jana Remlinger, Marine Massy, Dmitri Lodygin, Anke Salmen

Cells· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.
Jana Remlinger, Adrian Madarasz, Kirsten Guse, Robert Hoepner, Maud Bagnoud

Neurol Neuroimmunol Neuroinflamm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses.
Judit Gili-Kovács, Robert Hoepner, Anke Salmen, Maud Bagnoud, Ralf Gold

Ther Adv Neurol Disord· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.
Andrei Miclea, Maud Bagnoud, Andrew Chan, Robert Hoepner

Front Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis.
Maud Bagnoud, Myriam Briner, Jana Remlinger, Ivo Meli, Sara Schuetz

Cells· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis.
Robert Hoepner, Maud Bagnoud, Maximilian Pistor, Anke Salmen, Myriam Briner

Acta Neuropathol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course.
Greta Zoehner, Andrei Miclea, Anke Salmen, Nicole Kamber, Lara Diem, Maud Bagnoud

Ther Adv Neurol Disord· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age.
Myriam Briner, Maud Bagnoud, Andrei Miclea, Christoph Friedli, Lara Diem

Ther Adv Neurol Disord· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis